Saturday, 19 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14436
Articles
Company
Drug
CStone’s PD-L1 Inhibitor Sugemalimab Accepted for Review in Gastric Cancer
January 16, 2025
Company
Immorna Closes Series A+ and A++ Rounds Near $100M for mRNA Development
April 2, 2025
Company
Drug
Sanofi’s VaxigripTetra Approved for Pediatric Influenza Vaccination in China
January 16, 2025
Company
Drug
Enhertu Approved in China for HER2-Positive Breast Cancer
January 16, 2025
Company
Drug
Novartis’ Revolade Approved for Severe Aplastic Anemia in China
January 16, 2025
Company
Deals
Kelun-Biotech Files for Hong Kong IPO with Goldman Sachs and CITIC Securities
January 16, 2025
Company
Drug
Accutar Biotech Begins Phase I Trial for AC0176 in China
January 16, 2025
Company
Drug
BeiGene’s Tislelizumab Approved for Gastric Tumors in China
January 16, 2025
Company
Deals
SciClone Partners with Cowell Health to Enhance Cancer Treatment Accessibility
January 16, 2025
Company
Deals
Baheal Pharmaceutical Partners with Novartis for Votrient Commercialization
January 16, 2025
Company
Drug
Grand Pharma’s First-in-Class RDC ITM-11 Accepted for IND Review
January 16, 2025
Company
Deals
Jacobio Pharma Partners with WestChina-Frontier for Preclinical Safety Studies
January 16, 2025
1
2
…
1,023
1,024
1,025
1,026
1,027
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?